Premarin vaginal cream is a prescription estrogen therapy used to treat vaginal and vulvar changes caused by menopause. It has two FDA-approved uses: treating vaginal atrophy (thinning, drying, and inflammation of vaginal tissue) and treating moderate to severe pain during sexual intercourse that results from those tissue changes. The cream delivers estrogen directly to vaginal and vulvar tissue, restoring moisture and thickness that decline when the body’s natural estrogen production drops.
What Premarin Cream Treats
During and after menopause, falling estrogen levels cause the vaginal lining to become thinner, drier, and less elastic. This condition, known as vaginal atrophy, can produce persistent dryness, itching, burning, and irritation in and around the vagina. Premarin cream supplies a mixture of conjugated estrogens directly to the affected tissue, helping to rebuild the vaginal lining and restore its natural moisture.
The cream is also approved specifically for painful intercourse caused by these tissue changes. As vaginal walls thin and lose lubrication, sex can become uncomfortable or outright painful. By replenishing estrogen locally, the cream helps tissue regain enough thickness and flexibility to reduce that pain significantly.
A related condition called kraurosis vulvae, which involves chronic shrinking, drying, and irritation of the vulvar skin, is also treated with Premarin cream. This condition causes intense itching and can make the skin around the vulva appear white and thin. The same estrogen delivery that restores vaginal tissue also helps reverse these vulvar changes.
How the Cream Is Used
Premarin cream comes with a reusable applicator that measures the dose. The standard starting dose is 0.5 grams, though your prescriber may adjust this anywhere from 0.5 to 2 grams based on how you respond.
The dosing schedule depends on what’s being treated. For vaginal atrophy and vulvar changes, the cream is typically applied once daily on a cyclic schedule: 21 days of use followed by 7 days off. For painful intercourse, the dose is lower and less frequent. You apply 0.5 grams twice a week (for example, Monday and Thursday), either continuously or on the same 21-days-on, 7-days-off cycle.
This cyclic approach limits the total amount of estrogen your body absorbs over time. Because the cream is applied locally rather than taken as a pill, far less estrogen enters the bloodstream compared to oral hormone therapy, but some systemic absorption still occurs.
What to Expect From Treatment
Most women don’t notice dramatic improvement overnight. The vaginal lining needs time to respond to estrogen and rebuild. Many women begin to notice reduced dryness and less irritation within the first few weeks of consistent use, with continued improvement over the first one to three months. Pain during intercourse typically improves as the tissue thickens and produces more natural lubrication.
Because vaginal atrophy is a chronic condition that persists as long as estrogen levels remain low, symptoms generally return if you stop using the cream. Treatment is often long-term, and your prescriber will periodically reassess whether continuing makes sense for you.
Common Side Effects
The most commonly reported side effects are local reactions at the application site: vaginal discharge, mild irritation, or a feeling of fullness. Some women experience breast tenderness, headaches, or abdominal discomfort. These effects are generally mild and often improve as your body adjusts to the medication over the first few weeks.
Because some estrogen is absorbed into the bloodstream, the cream carries the same class of warnings as other estrogen products, though the risk is considered lower with vaginal application due to the smaller dose. The most serious potential concerns involve blood clots, stroke, and a possible increase in the risk of certain cancers with prolonged use.
Who Should Not Use It
Premarin cream is not appropriate for everyone. You should not use it if you have:
- Undiagnosed vaginal bleeding
- A history of breast cancer or any cancer that grows in response to estrogen
- A history of blood clots in the legs (deep vein thrombosis) or lungs (pulmonary embolism)
- A history of stroke or heart attack
- Active liver disease
- A known clotting disorder, such as protein C or protein S deficiency
- Known or suspected pregnancy
- A previous allergic reaction to the cream or its ingredients
Breast Cancer History and Vaginal Estrogen
The relationship between vaginal estrogen and breast cancer risk is one of the most discussed topics in menopause care. FDA labeling lists a history of breast cancer as a contraindication to all estrogen products, including vaginal creams. However, the clinical picture is more nuanced than the label suggests.
A large Finnish observational study found no elevated risk of new breast cancer associated with vaginal estrogen use. A separate study found that local estrogen was not associated with increased recurrence in women who had already been treated for breast cancer. Still, these are observational findings, not the gold-standard randomized trials that would settle the question definitively.
The North American Menopause Society recommends that nonhormonal treatments be tried first in women with a breast cancer history. If those fail, vaginal estrogen may be considered on a case-by-case basis through a shared decision between the patient and her oncologist. For women with triple-negative breast cancer (a type that doesn’t respond to hormone manipulation), the society considers local estrogen a more reasonable option since lowering estrogen isn’t part of their cancer treatment strategy.
How It Compares to Other Options
Premarin cream is one of several vaginal estrogen products available. Alternatives include estrogen tablets inserted vaginally, estrogen-releasing rings, and vaginal inserts containing a different hormone precursor (DHEA). All of these deliver hormones locally and work on the same principle of restoring tissue health.
For women who prefer to avoid hormones entirely, over-the-counter vaginal moisturizers used several times a week and water-based lubricants during intercourse can help manage milder symptoms. The North American Menopause Society positions these nonhormone approaches as first-line options, with prescription estrogen therapy reserved for women whose symptoms don’t respond adequately. Compounded hormone creams from specialty pharmacies are generally not recommended due to inconsistent dosing and lack of FDA oversight.